Skip to content

The Effects of Auditory Cueing on Rhythmic Movement and Cortical Excitability in Patients With Parkinson's Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02037451
Enrollment
38
Registered
2014-01-16
Start date
2013-08-31
Completion date
2014-08-31
Last updated
2014-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Parkinson's disease, Auditory Cueing

Brief summary

Parkinson's disease (PD) is a progressive degenerative disease of central nervous systems deficit. The clinical symptoms of Parkinson's disease include the following motor tasks: difficult in initiating movement, performing rhythmic movement or serial movement, the ability of learning motor movement is also affected. The primary treatment for Parkinson's disease is medical treatment; surgery is used if in need. Rehabilitation such as physical therapy, which aims to improve patient's quality of life and functions, is a non-invasive treatment and value for PD patients. Auditory cue is a technique that widely applied on training patients with Parkinson's disease, and some researches revealed that auditory cueing could improve motor performance. However, the mechanism under this treatment technique is still unknown. This study is to investigate the effect of auditory cueing on rhythmic finger movement in patients with Parkinson's disease. To investigate the mechanism under auditory cueing, neurophysiological data such as motor cortex excitability and blood flow in cortical cortex will be obtained by using Transcranial magnetic stimulation (TMS) and near infrared spectroscopy (NIRS).

Interventions

Participants perform the finger tapping at the same time give rhythmic auditory stimulation ,and need to execute tapping with auditory stimulation.

Sponsors

Chang Gung University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Parkinson disease

Exclusion criteria

* Clinical diagnosis of other neurological diseases * Dementia * Been diagnosed with any mental illness * History of seizures * Brain trauma * Body with a pacemaker or other electrical stimulator * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Finger TappingBaseline,45-60 minutes.Record pre-test and post-test change.
Motor evoked potentialBaseline,45-60 minuteUse single-pulse TMS to assess Motor evoked potential change.
Intracortical inhibition & Intracortical facilitationBaseline,45-60 minutesUse paired-pulse TMS to record pre-test and post-test change.
Blood oxygen dependent levelBaseline, in experiment,45-60 minutesUse Near-infrared spectroscopy to record pre-test, in experiment, and post-test change.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026